PURIFICATION AND PARTIAL CHARACTERIZATION OF RAT-LIVER SOLUBLE CATECHOL-O-METHYLTRANSFERASE

被引:37
作者
TILGMANN, C
KALKKINEN, N
机构
[1] UNIV HELSINKI,INST BIOTECHNOL,KARVAAMOKUJA 3,SF-00380 HELSINKI,FINLAND
[2] ORION CORP,GENET ENGN LAB,SF-00380 HELSINKI,FINLAND
关键词
Catechol-O-methyltransferase; soluble; Methylating enzyme;
D O I
10.1016/0014-5793(90)80774-D
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The rat liver soluble catechol-O-methyltransferase (EC 2.1.1.6.) has been purified utilizing a combination of conventional chromatography and HPLC. The purified enzyme has a molecular mass of 25 kDa, a pI of 5.1, and exists in two forms which differ in the nature of their intramolecular disulfide bonds. This difference causes these two protein forms to behave differently in reversed phase chromatography. © 1990.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 50 条
[21]   Polymorphisms in the Catechol-O-Methyltransferase Gene and Delirium in the Elderly [J].
van Munster, Barbara C. ;
Baas, Frank ;
Tanck, Michael W. ;
de Rooij, Sophia E. J. A. .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (05) :358-362
[22]   Inhibitors of catechol-O-methyltransferase sensitize mice to pain [J].
Kambur, O. ;
Talka, R. ;
Ansah, O. B. ;
Kontinen, V. K. ;
Pertovaara, A. ;
Kalso, E. ;
Mannisto, P. T. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) :1553-1565
[23]   Catechol-O-methyltransferase decreases levodopa toxicity in vitro [J].
Offen, D ;
Panet, H ;
Galili-Mosberg, R ;
Melamed, E .
CLINICAL NEUROPHARMACOLOGY, 2001, 24 (01) :27-30
[24]   Inhibitory Effect of Bovine Lactoferrin on Catechol-O-Methyltransferase [J].
Ikeda, Masayuki ;
Iijima, Hiroshi ;
Shinoda, Ichizo ;
Iwamoto, Hiroshi ;
Takeda, Yasuhiro .
MOLECULES, 2017, 22 (08)
[25]   Determination of differential activities of soluble and membrane-bound catechol-O-methyltransferase in tissues and erythrocytes [J].
Ellingson, T ;
Duddempudi, S ;
Greenberg, BD ;
Hooper, D ;
Eisenhofer, G .
JOURNAL OF CHROMATOGRAPHY B, 1999, 729 (1-2) :347-353
[26]   Comparative study on the interaction of recombinant human soluble catechol-O-methyltransferase on some hydrophobic adsorbents [J].
Passarinha, L. A. ;
Bonifacio, M. J. ;
Queiroz, J. A. .
BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (04) :430-438
[27]   Significance of the catechol-O-methyltransferase gene polymorphism in migraine [J].
Erdal, ME ;
Herken, H ;
Yilmaz, M ;
Bayazit, YA .
MOLECULAR BRAIN RESEARCH, 2001, 94 (1-2) :193-196
[28]   Association between catechol-O-methyltransferase polymorphism and vitiligo [J].
Türsen, Ü ;
Kaya, TI ;
Erdal, ME ;
Derici, E ;
Gündüz, Ö ;
Ikizoglu, G .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2002, 294 (03) :143-146
[29]   Pharmacodynamic evaluation of novel Catechol-O-methyltransferase inhibitors [J].
Pinheiro, Sofia Dimitri ;
Serrao, Maria Paula ;
Silva, Tiago ;
Borges, Fernanda ;
Soares-da-Silva, Patricio .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 847 :53-60
[30]   Catechol-O-methyltransferase: potential relationship to idiopathic hypertension [J].
Mantione, Kirk J. ;
Kream, Richard M. ;
Stefano, George B. .
ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (03) :291-295